Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2025-12-25 @ 8:49 PM
Study NCT ID:
NCT03055169
Status:
COMPLETED
Last Update Posted:
2018-05-03
First Post:
2016-07-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
TCF7L2 Polymorphisms Influence on Glycemic Control in ICU Patients With Organ Failure
Sponsor:
University Hospital, Lille
Organization:
Study Overview
Official Title:
TCF7L2 Polymorphisms Influence on Glycemic Control in ICU Patients With Organ Failure
Status:
COMPLETED
Status Verified Date:
2018-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
READIAB-G4
Brief Summary:
This study evaluates the link between genetic polymorphisms as r7903146, rs12255372 of TCF7L2 gene and the risk of developing hyperglycemia during Intensive care unit stay
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 2010-A00997-32 | OTHER | ID-RCB number, ANSM | View |